Expression of gelatinase B and the extracellular matrix metalloproteinase inducer EMMPRIN in benign and malignant pigment cell lesions of the skin

American Journal of Pathology

Volumn 151, Issue 3, 1997, Pages 665-670

  Van Den Oord, Joost J ^a   Paemen, Liesbet ^b   Opdenakker, Ghislain ^b   De Wolf Peeters, Chris ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 4; GELATINASE B; MATRIX METALLOPROTEINASE;

ARTICLE; BASEMENT MEMBRANE; BLUE NEVUS; CELL GROWTH; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALIGNANT LENTIGO; MELANOCYTE; MELANOMA; PIGMENT CELL; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

ANTIGENS, CD; ANTIGENS, CD147; ANTIGENS, NEOPLASM; BIOPSY; COLLAGENASES; HUMANS; IMMUNOHISTOCHEMISTRY; MATRIX METALLOPROTEINASE 9; MELANOCYTES; MELANOMA; MEMBRANE GLYCOPROTEINS; NEVUS, PIGMENTED; SKIN; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0030884405     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Liotta LA, Stetler-Stevenson WG: Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res 1991, 51:5054s-5059s
2. Gottesman M: The role of proteases in cancer. Semin Cancer Biol 1990, 1:97-160
3. Stetler-Stevenson WG: Type IV collagenases in tumor invasion and metastasis. Cancer Metastasis Rev 1990, 9:289-303
4. Albini A, Melchiori A, Santi L, Liotta LA, Brown PD, Stetler-Stevenson WG: Tumor cell invasion inhibited by TIMP-2. J Natl Cancer Inst 1991, 83:775-779
5. r 92,000 gelatinase release correlates with the metastatic phenotype in transformed rat embryo cells. Cancer Res 1990, 50:3872-3877
6. Sato H, Kida Y, Mai M, Endo Y, Sasaki T, Tanaka J, Seiki M: Expression of genes encoding type IV collagen-degrading metalloproteinases and tissue inhibitors of metalloproteinases in various human tumor cells. Oncogene 1992, 7:77-83
7. Houde M, de Bruyne G, Bracke M, Ingelman-Sundberg M, Skoglund G, Masure S, Van Damme J, Opdenakker G: Differential regulation of gelatinase B and tissue-type plasminogen activator expression in human Bowes melanoma cells. Int J Cancer 1993, 53:395-400
8. Biswas C, Zhang Y, DeCastro R, Guo H, Nakamura T, Kataoka H, Nabeshima K: The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily. Cancer Res 1995, 55:434-439
9. r 72,000 and 92,000 type IV collagenase in human skin cancers by in situ hybridization. Cancer Res 1992, 52:1336-1341
10. Pyke C, Ralfkiaer E, Tryggvason K, Danø K: Messenger RNA for two type IV collagenases is located in stromal cells in human colon cancer. Am J Pathol 1993, 142:359-365
11. Kataoka H, DeCastro R, Zucker S, Biswas C: Tumor cell-derived collagenase-stimulatory factor increases expression of interstitial collagenase, stromelysin and 72-kDa gelatinase. Cancer Res 1993, 53:3154-3158
12. Paemen L, Martens E, Masure S, Opdenakker G: Monoclonal antibodies specific for natural human neutrophil gelatinase B used for affinity purification, quantitation by two-site ELISA and inhibition of enzymatic activity. Eur J Biochem 1995, 234:759-765
13. Grillet B, Dequeker J, Paemen L, Van Damme B, Opdenakker G: Gelatinase B in chronic synovitis: immunolocalization with a monoclonal antibody. Br J Rheumatol 1997, 36:744-747
14. Hansmann C, Ebel T, Koch C, Prager E, Majdic O, Knapp W, Stockinger H: Identification and characterization of anti-M6 monoclonal antibodies (pre-CD neurothelin). Tissue Antigens 1996, 48:414
15. Majdic O, Stockinger H, Kohl P, Pickl WF, Knapp W: Reactivity and epitope-mapping of anti-M6 mabs (pre-CD neurothelin). Tissue Antigens 1996, 48:414
16. Väisänen A, Tuominen H, Kallioinen M, Turpeenniemi-Hujanen T: Matrix metalloproteinase-2 (72 kD type IV collagenase) expression occurs in the early stage of human melanocytic tumour progression and may have prognostic value. J Pathol 1996, 180:283-289
17. Barnhill RL: Pathology of melanocytic nevi and malignant melanoma. Boston, Butterworth-Heinemann, 1995, pp 142-147
18. Clark WH, Elder DE, Guerry D, Epstein MN, Greene MH, Van Horn M: A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma. Hum Pathol 1984, 15:1147-1165
19. Ray JM, Stetler-Stevenson WG: Gelatinase A activity directly modulates melanoma cell adhesion and spreading. EMBO J 1995, 14:908-917
20. Real FX, Houghton AN, Albino AP, Cordon-Cardo C, Melamed MR, Oettgen HF, Old LJ: Surface antigens of melanomas and melanocytes defined by mouse monoclonal antibodies: specificity analysis and comparison of antigen expression in cultured cells and tissues. Cancer Res 1985, 45:4401-4411
21. Clark WH, Tucker MA, Goldstein AM: Parenchymal-stromal interactions in neoplasia. Acta Oncol 1995, 34:749-752
22. MacDougall JR, Bani MR, Lin Y, Rak J, Kerbel RS: The 92-kDa gelatinase B is expressed by advanced stage melanoma cells: suppression by somatic cell hybridization with early stage melanoma cells. Cancer Res 1995, 55:4174-4184
23. Montgomery AM, Mueller BM, Reisfeld RA, Taylor SM, DeClerck YA: Effect of tissue inhibitor of the matrix metalloproteinases-2 expression on the growth and spontaneous metastasis of a human melanoma cell line. Cancer Res 1994, 54:5467-5473
24. Kato Y, Nakayama Y, Umeda M, Miyazaki K: Induction of 103-kDa gelatinase/type IV collagenase by acidic culture conditions in mouse metastatic melanoma cell lines. J Biol Chem 1992, 267:11424-11430
25. Reed RJ: A classification of melanocytic dysplasias and malignant melanomas. Am J Dermatopathol 1984, 6:195-206